Use of cardiac resynchronization therapy to optimize beta-blocker therapy in patients with heart failure and prolonged QRS duration

被引：34

作者：

Aranda, JM ^{[1
]}

Woo, GW ^{[1
]}

Conti, JB ^{[1
]}

Schofield, RS ^{[1
]}

Conti, CR ^{[1
]}

Hill, JA ^{[1
]}

机构：

[1] Univ Florida, Coll Med, Div Cardiovasc Med, Gainesville, FL 32610 USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2005年 / 95卷 / 07期

关键词：

D O I：

10.1016/j.amjcard.2004.12.023

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A retrospective analysis was performed on 52 patients with heart failure to determine the change in beta-blocker therapy after cardiac resynchronization therapy (CRT). After 6 months of CRT, the number of patients receiving beta-blocker therapy increased from 36 to 44, with improved clinical outcomes and larger beta-blocker doses, indicating that these 2 therapies may work together to improve outcomes by allowing the use of larger doses of beta blockers while correcting ventricular dyssynchrony. (c) 2005 by Excerpta Medica Inc.

引用

页码：889 / 891

页数：3

共 12 条

[1] Cardiac resynchronization in chronic heart failure [J].

Abraham, WT ;

Fisher, WG ;

Smith, AL ;

Delurgio, DB ;

Leon, AR ;

Loh, E ;

Kocovic, DZ ;

Packer, M ;

Clavell, AL ;

Hayes, DL ;

Ellestad, M ;

Messenger, J ;

Trupp, RJ ;

Underwood, J ;

Pickering, F ;

Truex, C ;

McAtee, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (24) :1845-1853

[2] Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure [J].

Bristow, MR ;

Saxon, LA ;

Boehmer, J ;

Krueger, S ;

Kass, DA ;

De Marco, T ;

Carson, P ;

DiCarlo, L ;

DeMets, D ;

White, BG ;

DeVries, DW ;

Feldman, AM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2140-2150

[3] A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure [J].

Cohn, JN ;

Tognoni, G .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) :1667-1675

[4] Influence of carvedilol on hospitalizations in heart failure: Incidence, resource utilization and costs [J].

Fowler, MB ;

Vera-Llonch, N ;

Oster, G ;

Bristow, MR ;

Cohn, JN ;

Colucci, WS ;

Gilbert, EM ;

Lukas, MA ;

Lacey, MJ ;

Richner, R ;

Young, ST ;

Packer, M .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (06) :1692-1699

[5]

Gregoratos Gabriel, 2002, Circulation, V106, P2145, DOI 10.1161/01.CIR.0000035996.46455.09

[6]

Hjalmarson Å, 1999, LANCET, V353, P2001

[7]

Lechat P, 1999, LANCET, V353, P9

[8] Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure [J].

Leclercq, C ;

Cazeau, S ;

Le Breton, H ;

Ritter, P ;

Mabo, P ;

Gras, D ;

Pavin, D ;

Lazarus, A ;

Daubert, JC .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (07) :1825-1831

[9] Effect of carvedilol on survival in severe chronic heart failure. [J].

Packer, M ;

Coats, AJS ;

Fowler, MB ;

Katus, HA ;

Krum, H ;

Mohacsi, P ;

Rouleau, JL ;

Tendera, M ;

Castaigne, A ;

Roecker, EB ;

Schultz, MK ;

DeMets, DL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (22) :1651-1658

[10] The effect of carvedilol on morbidity and mortality in patients with chronic heart failure [J].

Packer, M ;

Bristow, MR ;

Cohn, JN ;

Colucci, WS ;

Fowler, MB ;

Gilbert, EM ;

Shusterman, NH .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (21) :1349-1355

← 1 2 →